When it comes to seeking the best oncologist in Vizag or even in India, Dr B Ravi Shankar stands out as a top choice. With a specialization in Clinical Oncology, he has established himself as one of the leading experts in the field. His expertise and dedication have earned him the reputation of bein

2 views • 6 slides

Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of canc

0 views • 5 slides

Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification), Application (Oncology, Non-oncology) End User (Pharma, Academics, Hospitals) \u2013 Global Forecast to 2030\n

0 views • 4 slides

In the field of oncology care, the importance of effective management to reduce burnout among healthcare providers is highlighted. Stress, psychosocial risks, and burnout definitions are explored, emphasizing the impact on healthcare professionals' well-being and job satisfaction. Studies reveal hig

2 views • 69 slides

Explore how the COVID-19 pandemic has spurred the adoption of telehealth in oncology, as discussed by Dr. Samantha Jaglowski from The Ohio State University. Discover the rationale, barriers, implementation strategies, and future directions for telehealth in cancer care.

3 views • 59 slides

\n\nGemtuzumab 4.5 mg is a monoclonal antibody that targets CD33 antigen, which is found on the surface of leukemia cells. In precision oncology, this drug has been used to treat patients with acute myeloid leukemia (AML) who are deemed appropriate for this therapy. It has been shown to increase sur

1 views • 3 slides

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. \n\nRegister Now @ \/\/events.marketsandmarkets.com\/immuno-on

1 views • 6 slides

RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post Market Surveillance), End User (Pharma, Payer, Provider) - Global Forecast to 2029

1 views • 3 slides

This module provides training on medical terminology basics for patient navigators in oncology. It covers defining terms using prefixes, root words, and suffixes, common oncology words, and available resources. Learn how to approach medical terminology effectively by understanding word roots and com

1 views • 20 slides

Lujia Chen, a Postdoc Associate at the University of Pittsburgh, focuses on developing deep learning models for precision oncology. By utilizing machine learning, especially deep learning models, Chen aims to identify cancer signaling pathways, predict drug sensitivities, and personalize cancer trea

1 views • 5 slides

The Objective Structured Clinical Examination (OSCE) is a modern examination method widely used in the field of health science to evaluate clinical skill performance. It involves stations where medical students interact with simulated patients to demonstrate competencies such as history taking, phys

1 views • 40 slides

Providing an overview of patient navigation in oncology, this educational material covers social determinants of health, patient navigation history, core competencies, and models in the field. Supported by the CDC, it discusses disparities in healthcare access and the impact on medically underserved

2 views • 37 slides

This content delves into the essentials of patient navigation in oncology, covering competencies, professional roles, responsibilities, and functions of patient navigators. It highlights the importance of patient empowerment, communication, cultural competency, and care coordination. The material al

0 views • 43 slides

NIMH's Clinical Monitoring and Clinical Research Education, Support, and Training Program (CREST) aims to ensure the proper conduct, recording, and reporting of clinical trials. This program includes clinical monitoring plans, guidelines for site monitoring activities, and independent clinical monit

1 views • 29 slides

This module delves into the fundamentals of health care navigation with a focus on oncology patients. It covers the core competencies for patient navigators, compares hospital structures, explores cancer care delivery methods, discusses inpatient and outpatient care, and highlights different types o

0 views • 32 slides

Integrative oncology blends conventional cancer treatments with mind-body practices, natural products, and lifestyle modifications to improve health, quality of life, and clinical outcomes. This approach empowers individuals to actively participate in their care journey, promoting overall well-being

0 views • 18 slides

The European Patients Academy on Therapeutic Innovation focuses on the non-clinical development phase of medicine, delving into efficacy assessment, safety evaluation, and manufacturing process considerations. Non-clinical studies are essential for decision-making in clinical trials, marketing appli

1 views • 26 slides

This module focuses on Program Evaluation and Quality Improvement for Patient Navigators in oncology, covering competencies, learning objectives, definitions, and reasons for evaluation. It emphasizes the importance of evaluating programs to improve effectiveness, secure funding, meet accreditation

0 views • 39 slides

The concept of estimands in oncology clinical trials plays a crucial role in defining treatment effects and analyzing overall survival outcomes. This framework aims to enhance transparency, align trial objectives, and strengthen interdisciplinary dialogues. Introduced by the ICH E9(R1) guideline in

0 views • 14 slides

Explore the significance of social determinants of health and health disparities in the context of oncology patient navigation. Delve into the history, models, and core competencies of patient navigation while addressing the impact of medically underserved populations and cancer health disparities.

0 views • 37 slides

This educational curriculum emphasizes the importance of addressing psychiatric comorbidities in palliative care and psycho-oncology patients. It covers diagnostic challenges, evidence-based treatments, and screening for substance use disorders. The content also discusses the principles of palliativ

0 views • 53 slides

Understanding the significance of physical therapy in pediatric oncology, this resource emphasizes early screening and intervention to minimize long-term impairments for children with cancer. It covers identifying side effects of cancer treatment, typical motor development, the role of physical ther

0 views • 32 slides

Provide an overview of common Musculoskeletal (MSK) oncology pathology assessment, management principles, and preparation for FRCS. The agenda includes topics like soft tissue sarcomas, bone tumors, metastatic bone disease, vivas/cases, and guest speakers sharing valuable insights. Feedback is encou

0 views • 11 slides

This document lists contact information for various hospitals in the West Midlands area related to acute oncology services, including details of 24-hour advice lines, oncology nurses, consultants, and specific cancer service leads. Updates and changes to the information should be notified via email

0 views • 17 slides

The General Clinical Research Unit (GCRU) under Ridiane Denis offers support for a wide range of active protocols in various research areas like endocrinology, Alzheimer's, oncology, and more. GCRU provides clinical and laboratory services including sample processing, infusion, biopsy, urine analysi

0 views • 5 slides

Master protocols, seamless trials, and adaptive designs are revolutionizing oncology drug development. These innovative approaches involve multiple substudies with different objectives, evaluating investigational drugs across disease subtypes. Basket trials and umbrella trials offer flexibility in s

0 views • 13 slides

Latest update on hematological cancer clinical studies from the SWAG.Network Haematological Cancer Clinical Advisory Group, including national recruitment data, regional recruitment comparisons, open studies, and sample size information for ongoing studies. This comprehensive update covers a range o

0 views • 14 slides

Explore the shifting trends in oncology drug development, from understanding cancer mechanisms to new immuno-oncology approaches. Delve into the role of statisticians in researching cancer drugs and uncover the importance of early-phase trials in validating treatment mechanisms. Discover the need fo

0 views • 22 slides

Explore the intricate details of cancer treatment through precision oncology, focusing on cell of origin, genomic changes, tumor microenvironment, host factors, and response to various treatments such as chemotherapy, biological therapy, and immune therapy. The natural history and histology-guided c

0 views • 9 slides

This collection highlights clinical and pathological staging cases in oncology, covering scenarios from colon, lung, bladder, and kidney cancer. Each case presents detailed information on tumor characteristics, lymph node involvement, metastasis status, and clinical stages. Images accompany the desc

0 views • 9 slides

Patient feedback for the Neuro-Oncology services at Bristol Haematology Oncology Centre reflects a consistently positive experience. Patients found the staff to be supportive, informative, attentive, caring, and empathetic. The professionalism, humanism, kindness, and generosity of the oncology team

0 views • 9 slides

Bel Mondo Beauty introduces a breakthrough Moisture Renewal Mask made from bio cellulose, a fabric with incredible skin affinity and efficient ingredient transfer. This professional series mask targets oncology spa services, developed in collaboration with Oncology Spa Solutions to care for clients

0 views • 19 slides

Efficacy screening in oncology trials involves evaluating multiple tumor types simultaneously to enhance drug development efficiency. Basket trials minimize missed opportunities but risk cherry-picking for positive results. Statistical methods, like multiplicity control and Bayesian information borr

0 views • 19 slides

Comparison between sublobar resection and stereotactic ablative radiotherapy (SAbR) in high-risk patients with stage I non-small cell lung cancer has faced challenges like poor accrual, equipoise concerns among surgeons, and complex eligibility criteria. Traditional phase III trials struggle due to

0 views • 35 slides

This clinical audit focuses on evaluating the quality of dental screening and preventative management, including fluoride prescriptions, in head and neck oncology patients. The aim is to assess if the screenings meet best practice guidelines, with objectives related to dental screenings, OPG radiogr

0 views • 15 slides

Professional behavior characteristics play a crucial role in enhancing student learning during clinical education. This study examines the differences in reported importance and frequency of professional behaviors between credentialed and non-credentialed clinical instructors. The background outline

0 views • 28 slides

Sarcopenia and cachexia are prevalent issues in oncology, leading to muscle wasting, involuntary weight loss, and functional impairment. These conditions have various causes such as low energy intake, tumor treatments, inflammation, malnutrition, and infections. They can result in decreased quality

0 views • 11 slides

Clinical academics play a crucial role in integrating clinical practice, research, and education within the NHS. Collaboration between universities and NHS trusts is key to ensure clinical academics address the right questions for patient care and societal benefit. Challenges include an aging clinic

0 views • 29 slides

This presentation covers the pivotal role of Phase II trials in oncology drug development, emphasizing the importance of preliminary clinical efficacy screening, adverse event profiling, mechanism of action understanding, and target population definition. It discusses various Phase II trial designs,

0 views • 76 slides

The field of oncology presents unique opportunities for advancing drug development through novel therapeutic modalities like immunotherapies, cell and gene therapies, and radioligand therapies. However, regulators, sponsors, and payers face criticism, often due to non-significant results in overall

0 views • 16 slides